GSK PLC header image

GSK PLC

GSK

Equity

ISIN null / Valor 120042705

New York Stock Exchange, Inc (2026-04-02)
USD 56.69+1.25%

GSK PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

GSK PLC is a global healthcare company specializing in pharmaceuticals and vaccines, dedicated to preventing and treating a wide range of diseases. The company operates through key therapeutic areas including respiratory, immunology and inflammation, oncology, as well as HIV and other infectious diseases. Notably, GSK majority-owns ViiV Healthcare, the sole company exclusively focused on HIV treatment and prevention, aiming to end the HIV epidemic. With a robust portfolio of over 20 marketed vaccines, GSK delivers more than one million vaccine doses daily, addressing infectious diseases across all age groups. The company's approach emphasizes early intervention and the use of advanced technologies to support healthcare systems and improve patient outcomes. GSK's commitment to responsible business practices underpins its strategy for long-term growth and trust-building with stakeholders.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

50.6%1Y
59.4%3Y
26.6%5Y

Performance

28.3%1Y
63.8%3Y
51.6%5Y

Volatility

Market cap

113736 M

Market cap (USD)

Daily traded volume (Shares)

3,877,549

Daily traded volume (Shares)

1 day high/low

34.04 / 33.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.47%USD 162.43
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.60%USD 34.84
CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.60%USD 54.46
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.22%USD 546.89
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.11%USD 13.32
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.42%USD 35.11
BioVersys AG
BioVersys AG BioVersys AG Valor: 21036264
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.86%CHF 29.60
RHOEN-KLINIKUM AG
RHOEN-KLINIKUM AG RHOEN-KLINIKUM AG Valor: 341644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 12.50
Dynavox Group AB
Dynavox Group AB Dynavox Group AB Valor: 114900704
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.47%SEK 86.40
Evotec SE
Evotec SE Evotec SE Valor: 505433
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.03%EUR 4.50